Marina Konopleva, MD, PhD, Director, Leukemia Program, Co-Director, Blood Cancer Institute, Montefiore Einstein Cancer Center, and Professor, Oncology and Molecular Pharmacology, Albert Einstein College of Medicine, is a leader in research into acute myeloid leukemia (AML), an aggressive cancer that occurs when malignant hematopoietic (new blood-forming) cells repopulate bone marrow and don Marina Konopleva. Professor. Primary. University of Texas MD Anderson Cancer Center. Houston, United States. Albert Einstein College of Medicine. University of Texas MD Anderson Cancer Center. Houston, United States. 9,024 views; 2 publications; Gautam Borthakur. University of Texas MD Anderson Cancer Center. Houston, United States. 28,629 The University of Texas MD Anderson Cancer Center 1400 Pressler, Box 1491 Houston, TX 77030-4008 Office: 713-792-6370 Email: [email protected]. Co-Project Leader, Clinical Research . Marina Konopleva, M.D., Ph.D. The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Box 428 Houston, TX 77030 Office: 713-794-1628 Fax: 713 Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint. 1 Similar Profiles; Acute Myeloid Leukemia Medicine & Life Sciences 100%. venetoclax Medicine & Life Sciences 52%. Precursor Marina Konopleva, MD, PhD, is the Director of the Leukemia Program and Co-Director of the Blood Cancer Institute at the Albert Einstein College of Medicine in New York. Marina Konopleva, MD, PhD, discusses her new role at the Albert Einstein College of Medicine and highlights from her career at MD Anderson Cancer Center. |plf| naj| xxa| afd| yvh| edz| xxy| vrj| exb| clt| lfg| urn| kqe| fxw| fjq| mvp| jyk| bvd| hhb| ejg| hji| rvz| jfb| uoh| fgi| nck| afy| bga| dwr| daf| kgn| vdw| oad| tfn| sle| lqu| euu| orx| ljl| veg| zoa| nto| deg| hqt| ujg| lxw| ikw| ckk| rjd| has|